|
Diabetes Care, Vol 18, Issue 6 785-792, Copyright © 1995 by American Diabetes Association
The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study
N Chaturvedi, JM Stephenson and JH Fuller
Department of Epidemiology and Public Health, University College, London, U.K.
OBJECTIVE--To examine the relationship between smoking and both glycemic
control and microvascular complications in patients with insulin-dependent
diabetes mellitus (IDDM). RESEARCH DESIGN AND METHODS--This was a
prevalence survey of 3,250 men and women aged 15-60 years with IDDM from 31
diabetes centers in 16 European countries. Participants completed a
questionnaire, had retinal photographs taken, and performed a 24-h urine
collection. HbA1c, frequency of hypoglycemic and ketoacidotic episodes,
urinary albumin excretion rates, and retinopathy were compared by smoking
category. RESULTS--The prevalence of smoking was 35% in men and 29% in
women. Current smokers had poorer glycemic control and, among men, were
more likely to have had a ketoacidotic episode than were those who never
smoked. Ex-smokers had equivalent glycemic control and marginally more
hypoglycemic episodes did than those who never smoked. Current smokers had
a higher prevalence of microalbuminuria and total retinopathy than did
those who never smoked. Ex-smokers had a higher prevalence of
macroalbuminuria and proliferative retinopathy than did those who never
smoked, but both had a similar prevalence of microalbuminuria. Adjustment
for either current or long-term glycemic control could not fully account
for these differences. CONCLUSIONS--Smoking is associated with poorer
glycemic control and an increased prevalence of microvascular complications
compared with not smoking. Ex-smokers can achieve glycemic control
equivalent to and have a prevalence of early complications similar to that
of those who never smoked. We suggest that poorer glycemic control can
account for some of the increased risk of complications in smokers, and
that quitting smoking would be effective in reducing the incidence of
complications. Urgent action is required to reduce the high smoking rates
in people with IDDM.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Karter, M. R. Stevens, E. W. Gregg, A. F. Brown, C.-W. Tseng, D. G. Marrero, O. K. Duru, T. L. Gary, J. D. Piette, B. Waitzfelder, et al.
Educational Disparities in Rates of Smoking Among Diabetic Adults: The Translating Research Into Action for Diabetes Study
Am J Public Health,
February 1, 2008;
98(2):
365 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. T. Bloomgarden
Screening for and managing diabetic retinopathy: Current approaches
Am. J. Health Syst. Pharm.,
September 1, 2007;
64(17_Supplement_12):
S8 - S14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Caramori, P. Fioretto, and M. Mauer
Enhancing the Predictive Value of Urinary Albumin for Diabetic Nephropathy
J. Am. Soc. Nephrol.,
February 1, 2006;
17(2):
339 - 352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Mohsin, M. E Craig, J. Cusumano, A. K.F. Chan, S. Hing, J. W. Lee, M. Silink, N. J. Howard, and K. C. Donaghue
Discordant Trends in Microvascular Complications in Adolescents With Type 1 Diabetes From 1990 to 2002
Diabetes Care,
August 1, 2005;
28(8):
1974 - 1980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Bruno, F. Merletti, A. Biggeri, G. Bargero, S. Ferrero, G. Pagano, and P. C. Perin
Progression to Overt Nephropathy in Type 2 Diabetes: The Casale Monferrato Study
Diabetes Care,
July 1, 2003;
26(7):
2150 - 2155.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Egede and D. Zheng
Independent Factors Associated With Major Depressive Disorder in a National Sample of Individuals With Diabetes
Diabetes Care,
January 1, 2003;
26(1):
104 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Poulsen
Blood pressure and cardiac autonomic function in relation to risk factors and treatment perspectives in Type 1 diabetes
Journal of Renin-Angiotensin-Aldosterone System,
December 1, 2002;
3(4):
222 - 242.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Orth
Smoking and the Kidney
J. Am. Soc. Nephrol.,
June 1, 2002;
13(6):
1663 - 1672.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Rossing, P. Hougaard, and H.-H. Parving
Risk Factors for Development of Incipient and Overt Diabetic Nephropathy in Type 1 Diabetic Patients: A 10-year prospective observational study
Diabetes Care,
May 1, 2002;
25(5):
859 - 864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. E. Egede and D. Zheng
Modifiable Cardiovascular Risk Factors in Adults With Diabetes: Prevalence and Missed Opportunities for Physician Counseling
Arch Intern Med,
February 25, 2002;
162(4):
427 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Scott, J. H. Warram, L. S. Hanna, L. M. B. Laffel, L. Ryan, and A. S. Krolewski
A Nonlinear Effect of Hyperglycemia and Current Cigarette Smoking Are Major Determinants of the Onset of Microalbuminuria in Type 1 Diabetes
Diabetes,
December 1, 2001;
50(12):
2842 - 2849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zoppini, G. Faccini, M. Muggeo, L. Zenari, G. Falezza, and G. Targher
Elevated Plasma Levels of Soluble Receptors of TNF-{alpha} and Their Association with Smoking and Microvascular Complications in Young Adults with Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
August 1, 2001;
86(8):
3805 - 3808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Marshall, M. Bluestein, C. Chapin, T. Davis, J. Gersten, C. Harris, A. Hodgin, W. Larsen, H. Rigberg, V. Krishnaswami, et al.
Outpatient Management of Diabetes Mellitus in Five Arizona Medicare Managed Care Plans
American Journal of Medical Quality,
June 1, 1996;
11(2):
87 - 93.
[Abstract]
[PDF]
|
 |
|
Copyright © 1995 by the American Diabetes Association.
|
|
| |
|